Virus News and Research

Latest Virus News and Research

Computer vision system detects fever remotely to rule out COVID-19

People who approach the front desk at Albert Einstein Jewish Hospital (HIAE) in the city of São Paulo have their temperature taken remotely by a computer vision system installed in a nearby column.

29 Apr 2020

Study highlights biases and social implications in COVID-19 crisis

The biases individuals harbor against people they see as physically dirty emerge in children as young as five years old and persist into adulthood, according to a new study by researchers from Boston College and Franklin & Marshall College, who found these prejudices extend to the sick and may hold implications for people diagnosed with Covid-19.

29 Apr 2020

Men are twice more likely to die of COVID-19 than women

There have been studies that have revealed that men are more likely to get more severe symptoms from COVID-19 disease and also more likely to die from complications of the disease. A new study corroborates these findings. The study titled, “Gender differences in patients with COVID-19: Focus on severity and mortality,” is published in the latest issue of the journal Frontiers in Public Health.

29 Apr 2020

Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19

Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax, Inc. (EpiVax), a world leading informatics and immunology biotechnology company with a proven track record in vaccine development.

28 Apr 2020

French scientists suggest nicotinic agonists could treat COVID-19

Contrary to the warnings issued by health agencies worldwide against cigarette smoking amid the coronavirus disease (COVID-19), a new paper suggests the possibility that nicotine, a component of tobacco, could prevent coronavirus infection.

28 Apr 2020

How hospitals can prepare for an influx of COVID-19 cases

Hospitals and healthcare systems worldwide are overwhelmed, with many facilities full of patients requiring emergency care for coronavirus disease (COVID-19) that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 disease causes severe respiratory illness in patients, with some needing mechanical ventilation.

28 Apr 2020

Exploring the use of stem cells for COVID-19 disease

The coronavirus disease (COVID-19) has ravaged across the, infecting more than 3.11 million people in just over four months. As the virus continues to spread, scientists are struggling to find an effective treatment for the infection. Now, a breakthrough discovery on stem cells could help in the battle against COVID-19.

28 Apr 2020

Dominant SARS-CoV-2 strain A2a binds more easily to ACE2 receptors

The COVID-19 pandemic has affected almost all countries across the world, and India is no exception. Researchers have found that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone several mutations with time.

28 Apr 2020

Important insights into COVID-19 for worldwide strategic planning

Researchers in China and the United States have analyzed cases of early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and their close contacts to provide further insights into the disease’s transmission and severity and the effectiveness of control measures.

28 Apr 2020

New approach for easier detection of SARS-CoV-2 via swabs and saliva

A recent Israeli study points toward Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) as a potentially effective tool for acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on-the-spot detection by using swabs or saliva – addressing the community need for simple surveillance.

28 Apr 2020

COVID-19: Discrimination and inequality shape risk of severe illness and death

Underlying conditions that increase risk of severe illness or death from COVID-19 are much more common among Black, Native American, and lower-income people in the United States.

28 Apr 2020

UTHealth experts successfully treat 3-week-old infant with severe COVID-19

In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston/

28 Apr 2020

Boston Children's Hospital launches two-pronged study of COVID-19 in children

Boston Children's Hospital has launched a two-pronged study of COVID-19 disease among children and youth up to age 25 across the country, with $2.1 million in funding from the Centers for Disease Control and Prevention.

28 Apr 2020

Father's Toxoplasma infection can impact their offspring's brain health and behavior

Australian researchers have revealed for the first time that males infected with the Toxoplasma parasite can impact their offspring's brain health and behavior.

28 Apr 2020

Synthetic antibodies constructed using bacterial superglue could help fight lethal viruses

Synthetic antibodies constructed using bacterial superglue can neutralize potentially lethal viruses, according to a study published on April 21 in eLife.

28 Apr 2020

New nasopharyngeal swabs move into human trials for COVID-19

Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and research.

28 Apr 2020

Ayurveda and yoga could provide an effective, affordable means for COVID-19 prevention

Experts in Indian traditional medicine, including the chair of the Government of India's committee charged to lead that nation's efforts on the potential uses of traditional medicine relative to COVID-19, describe how the approach of Ayurveda and yoga may help strengthen host immunity and provide an effective, accessible, and affordable means of prophylaxis of COVID-19 infection.

28 Apr 2020